CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
D000995:Antitubercular Agents; D002207:Capreomycin; D003523:Cycloserine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D004977:Ethambutol; D005000:Ethionamide; D007612:Kanamycin; D010670:Phenylthiourea / Q000031:analogs & derivatives; D011718:Pyrazinamide; D019233:Retreatment; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary; D014756:Viomycin
D000995:Antitubercular Agents; D002207:Capreomycin; D011718:Pyrazinamide; C100189:thiocarlide; D007612:Kanamycin; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D014756:Viomycin
ANTITUBERCULAR AGENTS; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ETHAMBUTOL; ETHIONIAMIDE; KANAMYCIN; PYRAZINAMIDE; THIOCARLIDE; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY; VIOMYCIN